Targeted Inhibition of the Dual Specificity Phosphatases DUSP1 and DUSP6 Suppress MPNST Growth via JNK.
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Nov 2026 · 1 min read
In brief
In brief
This study investigates DUSP1 and DUSP6 phosphatases as therapeutic targets in malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1. Inhibition of these enzymes suppresses tumor growth through JNK pathway modulation, offering a potential targeted treatment approach for these aggressive sarcomas.
Written by the GCMD Library team from the article.
Statements in this article
Constitutively active RAS-GTP and increased MAPK signaling are important in tumorigenesis in neurofibromatosis type 1 and malignant peripheral nerve sheath tumors.
Dual specificity phosphatases are negative regulators of MAPK signaling that dephosphorylate p38, JNK, and ERK.
Targeted inhibition of DUSP1 and DUSP6 suppresses malignant peripheral nerve sheath tumor growth via JNK.